Prognostic performance of neutrophil CD64 expression in patients with complicated intra-abdominal infections – a prospective study

References

• Sartelli M, Catena F, Ansaloni L, et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW study. World J Emerg Surg. 2014;9:37. doi: 10.1186/1749-7922-9-37.
   PubMed Web of Science ®Google Scholar
• Qureshi SS, Lewis SM, Gant VA, et al. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS). Clin Exp Immunol. 2001;125(2):258–265. doi: 10.1046/j.1365-2249.2001.01596.x.
   PubMed Web of Science ®Google Scholar
• Hoffmann J. Neutrophil CD64 as a sepsis biomarker. Biochem Med. 2011;21(3):282–290. doi: 10.11613/bm.2011.038.
   PubMed Web of Science ®Google Scholar
• Li S, Huang X, Chen Z, et al. Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis. Int J Infect Dis. 2013;17(1):e12-23–e23. doi: 10.1016/j.ijid.2012.07.017.
   PubMed Web of Science ®Google Scholar
• Gerrits JH, McLaughlin PMJ, Nienhuis BN, et al. Polymorphic mononuclear neutrophils CD64 index for diagnosis of sepsis in postoperative surgical patients and critically ill patients. Clin Chem Lab Med. 2013;51(4):897–905. doi: 10.1515/cclm-2012-0279.
   PubMed Web of Science ®Google Scholar
• Icardi M, Erickson Y, Kilborn S, et al. CD64 index provides simple and predictive testing for detection and monitoring of sepsis and bacterial infection in hospital patients. J Clin Microbiol. 2009;47(12):3914–3919. doi: 10.1128/JCM.00628-09.
   PubMed Web of Science ®Google Scholar
• Dimitrov E, Enchev E, Halacheva K, et al. Neutrophil CD64–A potential biomarker in patients with complicated intra-abdominal infections?–A literature review. Acta Microbiol Immunol Hung. 2018;65(3):245–254. doi: 10.1556/030.65.2018.011.
   PubMed Web of Science ®Google Scholar
• Barie P, Hydo L, Eachempati S Longitudinal outcomes of intra-abdominal infection complicated by critical illness. Surg Infect. 2004;5(4):365–373. doi: 10.1089/sur.2004.5.365.
   PubMedGoogle Scholar
• Sartelli M, Abu-Zidan FM, Labricciosa FM, et al. Physiological parameters for prognosis in abdominal sepsis (PIPAS) study: a WSES observational study. World J Emerg Surg. 2019;14:34. doi: 10.1186/s13017-019-0253-2.
   PubMed Web of Science ®Google Scholar
• Silva-Nunes J, Cardoso T. Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment. BMC Infect Dis. 2019;19(1):980. doi: 10.1186/s12879-019-4604-0.
   PubMed Web of Science ®Google Scholar
• Pan J, Zhu Q, Zhang X, et al. Factors influencing the prognosis of patients with intra-abdominal infection and its value in assessing prognosis. Infect Drug Resist. 2021;14:3425–3432. doi: 10.2147/IDR.S325386.
   PubMed Web of Science ®Google Scholar
• Tridente A, Clarke GM, Walden A, et al. Association between trends in clinical variables and outcome in intensive care patients with faecal peritonitis: analysis of the GenOSept cohort. Crit Care. 2015;19(1):210. doi: 10.1186/s13054-015-0931-8.
   PubMedGoogle Scholar
• Blot S, Antonelli M, Arvaniti K, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: ‘AbSeS’, a multinational observational cohort study and ESICM trials group project. Intensive Care Med. 2019;45(12):1703–1717. doi: 10.1007/s00134-019-05819-3.
   PubMed Web of Science ®Google Scholar
• Tolonen M. 2019). Secondary peritonitis: assessment of severity and management of open abdomen Doctoral dissertation helda.helsinki.fi
   Google Scholar
• Rajaee A, Barnett R, Cheadle WG. Pathogen- and danger-associated molecular patterns and the cytokine response in sepsis. Surg Infect. 2018;19(2):107–116. doi: 10.1089/sur.2017.264.
   PubMed Web of Science ®Google Scholar
• Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585. doi: 10.1136/bmj.i1585.
   PubMed Web of Science ®Google Scholar
• Ross JT, Matthay MA, Harris HW. Secondary peritonitis: principles of diagnosis and intervention. BMJ. 2018;361:k1407–k1414. doi: 10.1136/bmj.k1407.
   PubMedGoogle Scholar
• Patnaik R, Azim A, Agarwal V. Neutrophil CD64 a diagnostic and prognostic marker of sepsis in adult critically ill patients: a brief review. Indian J Crit Care Med. 2020;24(12):1242–1250. doi: 10.5005/jp-journals-10071-23558.
   PubMed Web of Science ®Google Scholar
• Dimitrov E, Halacheva K, Enchev E, et al. The potential prognostic performance of neutrophil CD64 and monocyte HLA-DR in patients with complicated intra-abdominal infections. CIR. 2020;16(1):12–17. doi: 10.2174/1573395516666200312111456.
   Google Scholar
• Dimoula A, Pradier O, Kassengera Z, et al. Serial determinations of neutrophil CD64 expression for the diagnosis and monitoring of sepsis in critically ill patients. Clin Infect Dis. 2014; 58(6):820–829. doi: 10.1093/cid/cit936.
   PubMed Web of Science ®Google Scholar
• Chen Q, Shi J, Fei A, et al. Neutrophil CD64 expression is a predictor of mortality for patients in the intensive care unit. Int J Clin Exp Pathol. 2014;7(11):7806–7813.
   PubMed Web of Science ®Google Scholar
• Djordjevic D, Pejovic J, Surbatovic M, et al. Prognostic value AND daily trend OF interleukin-6, neutrophil cd64 expression, C-reactive protein AND lipopolysaccharide-binding protein IN critically ill patients: reliable predictors OF outcome OR not? J Med Biochem. 2015;34(4):431–439. doi: 10.1515/jomb-2015-0002.
   PubMed Web of Science ®Google Scholar
• Danikas DD, Karakantza M, Theodorou GL, et al. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis correlation to CD64 and CD14 antigen expression. Clin Exp Immunol. 2008;154(1):87–97. doi: 10.1111/j.1365-2249.2008.03737.x.
   PubMed Web of Science ®Google Scholar
• Cid J, García-Pardo G, Aguinaco R, et al. Neutrophil CD64: diagnostic accuracy and prognostic value in patients presenting to the emergency department. Eur J Clin Microbiol Infect Dis. 2011;30(7):845–852. doi: 10.1007/s10096-011-1164-7.
   PubMed Web of Science ®Google Scholar
• Lekka K, Marangos M, Roupas N, et al. Evaluation of the activity of neutrophils and monocytes in diabetic patients with sepsis, can surface antigens HLA-DR and CD64 be useful as prognostic factors? J Clin Med Res. 2020;12(3):157–164. doi: 10.14740/jocmr4068.
   PubMedGoogle Scholar
• Pandey K, Malviya DP, Awasthi N, et al. Comparison of neutrophil CD64 and monocytic HLA-DR with existing biomarkers for the diagnosis and prognosis of sepsis. Anaesthesiol Intensive Ther. 2021;53(4):304–311. doi: 10.5114/ait.2021.108579.
   PubMed Web of Science ®Google Scholar
• de Jong E, de Lange DW, Beishuizen A, et al. Neutrophil CD64 expression as a longitudinal biomarker for severe disease and acute infection in critically ill patients. Int J Lab Hematol. 2016;38(5):576–584. doi: 10.1111/ijlh.12545.
   PubMed Web of Science ®Google Scholar
• Velásquez S, Matute JD, Gámez LY, et al. Characterization of nCD64 expression in neutrophils and levels of s-TREM-1 and HMGB-1 in patients with suspected infection admitted in an emergency department. Biomedica. 2013;33(4):643–652.
   PubMed Web of Science ®Google Scholar
• Papadimitriou-Olivgeris M, Lekka K, Zisimopoulos K, et al. Role of CD64 expression on neutrophils in the diagnosis of sepsis and the prediction of mortality in adult critically ill patients. Diagn Microbiol Infect Dis. 2015;82(3):234–239. doi: 10.1016/j.diagmicrobio.2015.03.022.
   PubMed Web of Science ®Google Scholar